School of Medical Sciences, University of Auckland, Dunedin, New Zealand.
Infectious Disease Department, Auckland District Health Board, Dunedin, New Zealand.
Nephrology (Carlton). 2019 Jul;24(7):744-750. doi: 10.1111/nep.13474. Epub 2019 Apr 24.
For patients requiring haemodialysis, the risk of Staphylococcus aureus disease is higher in those colonized and persists while the person requires haemodialysis, necessitating frequent decolonization. However, the duration of successful decolonization is not known. This study aimed to determine the duration of efficacy of decolonization in intermittent and persistent S. aureus carriers requiring haemodialysis using two decolonization strategies.
We screened 100 outpatients requiring haemodialysis for S. aureus carriage and then decolonized 14 intermittent carriers and 18 persistent carriers. Participants were invited to undertake two decolonization attempts, using systemic or topical antibiotics 12 weeks apart. Nasal swabs were taken weekly to determine the duration of successful decolonization.
Decolonization was successful in 24/32 (75%) participants and the median duration of decolonization was 35 days (95% confidence interval (CI) 11-59). The median duration of S. aureus decolonization was significantly shorter for persistent carriers (19 days, 95% CI 13-25 days) in comparison with intermittent carriers (70 days, 95% CI 61-79 days; P < 0.01). 28/52 (54%) post-decolonization surveys indicated that they would use the treatment again, 14/52 (27%) surveys indicated that they would not use the treatment again, and 10/52 (19%) were undecided. 16/53 (30%) decolonization attempts resulted in an adverse drug reaction.
Staphylococcus aureus decolonization using topical or systemic treatments was successful for many haemodialysis patients, and provided a month free of S. aureus colonization. Although decolonization treatment provided a shorter duration of success for persistent carriers in comparison with intermittent carriers, persistent carriers are likely to gain the most from effective decolonization strategies.
对于需要血液透析的患者,金黄色葡萄球菌病的风险在定植的患者中更高,并且在需要血液透析期间持续存在,因此需要频繁进行去定植。然而,成功去定植的持续时间尚不清楚。本研究旨在确定使用两种去定植策略对需要血液透析的间歇性和持续性金黄色葡萄球菌携带者进行去定植的疗效持续时间。
我们筛选了 100 名需要血液透析的门诊患者,然后对 14 名间歇性携带者和 18 名持续性携带者进行了去定植。参与者被邀请进行两次去定植尝试,使用全身或局部抗生素,间隔 12 周。每周采集鼻拭子以确定成功去定植的持续时间。
32 名参与者中的 24 名(75%)去定植成功,去定植的中位持续时间为 35 天(95%置信区间 11-59)。与间歇性携带者相比,持续性携带者(19 天,95%置信区间 13-25 天)的金黄色葡萄球菌去定植中位持续时间明显更短(70 天,95%置信区间 61-79 天;P<0.01)。52 份去定植后调查中的 28 份(54%)表示他们将再次使用该治疗,14 份(27%)表示他们将不再使用该治疗,10 份(19%)表示不确定。53 次去定植尝试中有 16 次(30%)出现药物不良反应。
使用局部或全身治疗对许多血液透析患者进行金黄色葡萄球菌去定植是成功的,可以在一个月内无金黄色葡萄球菌定植。虽然与间歇性携带者相比,持续性携带者的去定植治疗持续时间较短,但持续性携带者可能从有效的去定植策略中获益最大。